Systematic review and meta-analysis: Patient and programme impact of fixed-dose combination antiretroviral therapy-Reference-Cited by-同舟云学术

Systematic review and meta-analysis: Patient and programme impact of fixed-dose combination antiretroviral therapy

Published:2014-03-17 Issue:5 Volume:19 Page:501-513
ISSN:1360-2276
Container-title:Tropical Medicine & International Health
language:en
Short-container-title:Trop Med Int Health

Author:

Ramjan Rubeena¹,Calmy Alexandra²³,Vitoria Marco⁴,Mills Edward J.⁵,Hill Andrew⁶,Cooke Graham¹,Ford Nathan⁴

Affiliation:

1. Department of Infectious Diseases; Faculty of Medicine; Imperial College; London UK

2. HIV/AIDS Unit; Infectious Disease Service; Geneva University Hospital; Geneva Switzerland

3. Médecins Sans Frontières; Geneva Switzerland

4. HIV/AIDS Department; World Health Organization; Geneva Switzerland

5. Faculty of Health Sciences; University of Ottawa; Ottawa Canada

6. Department of Pharmacology and Therapeutics; Liverpool University; Liverpool UK

Funder

BRC of Imperial College NHS Trust

NIHR National Point-of-care Diagnostics Evaluation Centre

Treatment Optimization

Bill & Melinda Gates Foundation

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Parasitology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tmi.12297/fullpdf

Reference42 articles.

1. One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects;Airoldi;Patient Preference and Adherence,2010

2. A single tablet regimen is associated with higher adherence and viral suppression than multiple tablet regimens in HIV+ homeless and marginally housed people;Bangsberg;AIDS,2010

3. Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies;Barnighausen;The Lancet Infectious Diseases,2011

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-line antiretroviral therapy initiation for newly diagnosed people with HIV in the Netherlands: A retrospective analysis from 2016 to 2020;PLOS ONE;2024-07-26

2. Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1;Infectious Diseases and Therapy;2024-07-04

3. Combating antimicrobial resistance in malaria, HIV and tuberculosis;Nature Reviews Drug Discovery;2024-05-15

4. Second-Line Switch to Dolutegravir for Treatment of HIV Infection;New England Journal of Medicine;2023-06-22

5. Bictegravir/emtricitabine/tenofovir alafenamide in a virologically suppressed adult with HIV and end-stage renal disease on chronic peritoneal dialysis: A case report;International Journal of STD & AIDS;2022-11-29